What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-03-27 compared with 2024-03-19 · 28 added, 41 removed, 15 unchanged (82% of the section changed)

MARKET FOR REGISTRANT’S COMMON

EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

MARKET FOR REGISTRANT’S

COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is listed on Nasdaq Global Select

Market, under the symbol “RLMD”.

As of March 15, 2024, 30,174,202shares of common

stock were issued and outstanding, which were held by 129 holders of record.

These stockholders held their stock either individually or

in nominee or “street” names through various brokerage firms.

There are no shares of our Class A convertible preferred stock

Our transfer agent is:

Market, under the symbol “RLMD.” On January 21, 2025, we received a written notification from the Listing Qualifications

Department of the Nasdaq Stock Market (“Nasdaq”) notifying us that, for the 30 consecutive business days ended January 17,

2025, the Company’s common stock did not maintain a minimum bid price of $1.00 per share.

Nasdaq stated in its letter that in accordance

with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days from the date of the notice (“Compliance

Period”), and that it may regain compliance if the closing bid of the Company’s security is at least $1 for a minimum of

ten consecutive business days during the Compliance Period, which will end on July 21, 2025.

We intend to actively monitor the bid price

of our common stock during the Compliance Period and to take all reasonable measures available to regain compliance with the requirements

for continued listing on the Nasdaq Global Market.

If we do not regain compliance with the continued listing requirements for the minimum

bid price by the end of the Compliance Period, the Nasdaq Staff will provide us with written notification that the common stock is subject

to delisting from the Nasdaq Global Market.

Alternatively, Nasdaq Marketplace Rules may permit the Company to transfer the our common

stock to the Nasdaq Capital Market prior to the Compliance Date, if the common stock satisfies the criteria for continued listing on

While we plan to make diligent efforts to maintain the listing of our common stock on Nasdaq, there can be no assurance

that we will be able to regain or maintain compliance with the applicable continued listing standards set forth in the Nasdaq Listing

As of March 25, 2025, 33,191,202 shares of common stock were issued

and outstanding, which were held by 123 holders of record.

These stockholders held their stock either individually or in nominee or “street”

names through various brokerage firms.

There are no shares of our Class A convertible preferred stock outstanding.

Our transfer agent

Empire Stock Transfer

11 unchanged sentences

on our financial condition, operating results, capital requirements and such other factors as our Board of Directors deems relevant.

Securities Authorized for Issuance under Equity

Compensation Plans

Relmada has a 2014 Option and Equity Incentive

Plan, as amended (the 2014 Plan) in which its directors, officers, employees and consultants shall be eligible to participate.

Plan allows for the granting of common stock awards, stock appreciation rights, and incentive and nonqualified stock options to purchase

shares of the Company.

On May 20, 2021, at the annual shareholders meeting, our shareholders approved our 2021 Equity Incentive Plan (the

2021 Plan) which allows for the granting of incentive and nonqualified stock options, stock appreciation rights, restricted stock awards,

performance share awards and other equity-based awards for up to 1,500,000 options or stock awards.

At the annual shareholders meeting

on May 25, 2022, our shareholders approved an amendment to the 2021 Plan to increase the shares of the Company’s common stock available

for issuance thereunder by 3,900,000 shares.

At the annual shareholders meeting on May 25, 2023, our shareholders approved an amendment

to the 2021 Plan to increase the shares of the Company’s common stock available for issuance thereunder by 2,500,000 shares.

the annual shareholders meeting (currently anticipated for May 24, 2024), our shareholders will vote on a management proposal to increase

the shares authorized for awards under the 2021 Plan by an additional 4,500,000 shares, but there can be no assurance such amendment will

With these grants and approvals, as of December 31, 2023, the Company had 136,750 shares available to be issued pursuant

to awards under the 2021 Plan.

The following table summarizes our equity compensation

plan information as of December 31, 2023:

Equity Compensation Plan Information

Plan Category

securities to be

options and stock

exercise price

of outstanding

available for

future issuance

plans (excluding

Equity compensation plans approved by security holders (1)

Equity compensation plans not approved by security holders

(1) The 2021 Equity Incentive Plan, as amended.

Unregistered Sales of Securities

There were no unregistered sales of securities

during the year ended December 31, 2024 that have not been previously reported in a Quarterly Report on Form 10-Q or in a Current Report

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity